Analysts expect Nutrien Ltd (NYSE:NTR) to post $0.26 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Nutrien’s earnings, with the lowest EPS estimate coming in at $0.18 and the highest estimate coming in at $0.37. Nutrien posted earnings of $0.16 per share during the same quarter last year, which suggests a positive year over year growth rate of 62.5%. The business is scheduled to report its next earnings results after the market closes on Thursday, May 9th.
According to Zacks, analysts expect that Nutrien will report full year earnings of $3.01 per share for the current year, with EPS estimates ranging from $2.77 to $3.29. For the next financial year, analysts anticipate that the business will report earnings of $3.48 per share, with EPS estimates ranging from $2.79 to $3.95. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that follow Nutrien.
Get Nutrien alerts: Nutrien (NYSE:NTR) last posted its quarterly earnings data on Wednesday, February 6th. The company reported $0.54 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.54. Nutrien had a return on equity of 12.95% and a net margin of 18.20%. The company had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.61 billion. Nutrien’s revenue was up 7.5% on a year-over-year basis.
NTR has been the topic of several recent research reports. Zacks Investment Research upgraded Nutrien from a “strong sell” rating to a “hold” rating in a report on Wednesday, April 10th. Cowen restated an “outperform” rating and set a $66.00 target price (down from $70.00) on shares of Nutrien in a report on Wednesday, March 6th. Raymond James restated a “strong-buy” rating and set a $70.00 target price on shares of Nutrien in a report on Thursday, February 7th. Citigroup lowered their target price on Nutrien from $66.00 to $56.00 and set a “buy” rating on the stock in a report on Monday, January 7th. Finally, Barclays restated a “buy” rating on shares of Nutrien in a report on Sunday, February 10th. Six equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Buy” and an average price target of $61.69.
NTR stock traded up $0.18 during trading on Friday, hitting $54.02. The stock had a trading volume of 1,215,742 shares, compared to its average volume of 1,600,199. Nutrien has a twelve month low of $43.96 and a twelve month high of $58.99. The stock has a market cap of $32.62 billion, a price-to-earnings ratio of 20.08, a PEG ratio of 1.67 and a beta of 0.79.
Several hedge funds have recently added to or reduced their stakes in the company. Point View Wealth Management Inc. raised its position in shares of Nutrien by 0.9% during the 4th quarter. Point View Wealth Management Inc. now owns 26,189 shares of the company’s stock valued at $1,231,000 after buying an additional 245 shares during the period. Proficio Capital Partners LLC raised its position in shares of Nutrien by 38.3% during the 4th quarter. Proficio Capital Partners LLC now owns 902 shares of the company’s stock valued at $42,000 after buying an additional 250 shares during the period. Usca Ria LLC raised its position in shares of Nutrien by 1.4% during the 4th quarter. Usca Ria LLC now owns 20,676 shares of the company’s stock valued at $972,000 after buying an additional 286 shares during the period. Cetera Advisors LLC raised its position in shares of Nutrien by 3.1% during the 4th quarter. Cetera Advisors LLC now owns 9,781 shares of the company’s stock valued at $461,000 after buying an additional 293 shares during the period. Finally, CLARET ASSET MANAGEMENT Corp raised its position in shares of Nutrien by 3.7% during the 4th quarter. CLARET ASSET MANAGEMENT Corp now owns 8,583 shares of the company’s stock valued at $403,000 after buying an additional 310 shares during the period. 66.09% of the stock is currently owned by hedge funds and other institutional investors.
Nutrien Ltd. produces and markets crop nutrients to agricultural, industrial, and feed customers worldwide. It operates in four segments: Retail, Potash, Nitrogen, and Phosphate and Sulfate. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating 1,700 retail locations.
Featured Article: Why do companies issue convertible shares?
Get a free copy of the Zacks research report on Nutrien (NTR)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nutrien analysts' ratings for Nutrien and related companies daily email newsletter .